Action Pharma A/S   Report issue

For profit Phase 2
Founded: Aarhus Denmark (2000)
Status: Acquired by Abbott (2012)

Organization Overview

First Clinical Trial
2008
NCT00628264
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

modimelanotide (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aneurysm (Phase 2)

Aortic Aneurysm (Phase 2)

Kidney Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1